Clodronate With or Without Chemotherapy and/or Hormonal Therapy in Treating Women With Stage I or Stage II Breast Cancer
Status:
Completed
Trial end date:
2012-12-01
Target enrollment:
Participant gender:
Summary
RATIONALE: Clodronate may be effective in preventing the spread of cancer to the bones and
other parts of the body. It is not yet known whether clodronate is more effective alone or
combined with chemotherapy and /or hormonal therapy in preventing metastatic breast cancer.
PURPOSE: Randomized phase III trial to determine the effectiveness of clodronate with or
without chemotherapy and /or hormonal therapy in preventing metastases in women who have
stage I or stage II breast cancer.
Phase:
Phase 3
Details
Lead Sponsor:
NSABP Foundation Inc
Collaborators:
National Cancer Institute (NCI) North Central Cancer Treatment Group Southwest Oncology Group